Mineralys Therapeutics, Inc.
General ticker "MLYS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B (TTM average)
Mineralys Therapeutics, Inc. follows the US Stock Market performance with the rate: 45.3%.
Estimated limits based on current volatility of 4.8%: low 25.38$, high 27.96$
Factors to consider:
- Total employees count: 12 as of 2022
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [18.82$, 45.12$]
- 2026-12-31 to 2027-12-31 estimated range: [12.28$, 31.26$]
Short-term MLYS quotes
Long-term MLYS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $84.66MM | $192.40MM | $170.60MM |
| Operating Income | $-84.66MM | $-192.40MM | $-170.60MM |
| Non-Operating Income | $12.76MM | $14.59MM | $15.95MM |
| R&D Expense | $70.36MM | $168.58MM | $132.01MM |
| Income(Loss) | $-71.90MM | $-177.81MM | $-154.65MM |
| Profit(Loss)* | $-71.90MM | $-177.81MM | $-154.65MM |
| Stockholders Equity | $241.15MM | $191.26MM | $646.69MM |
| Assets | $251.64MM | $205.90MM | $661.81MM |
| Operating Cash Flow | $-81.17MM | $-166.31MM | $-142.42MM |
| Capital expenditure | $0.00MM | $0.10MM | $0.01MM |
| Investing Cash Flow | $-160.47MM | $114.96MM | $-389.75MM |
| Financing Cash Flow | $203.25MM | $116.14MM | $591.00MM |
| Earnings Per Share** | $-1.99 | $-3.66 | $-2.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.